The neurodevelopmental hypothesis of The neurodevelopmental hypothesis of schizophrenia proposes that an early insult schizophrenia proposes that an early insult to the developing brain could result in brain to the developing brain could result in brain changes that are 'fixed', 'non-progressive' changes that are 'fixed', 'non-progressive' and lie 'dormant' until made manifest in and lie 'dormant' until made manifest in adolescence or early adulthood. This hy-adolescence or early adulthood. This hypothesis was promoted most recently in pothesis was promoted most recently in the 1980s (Lewis & Murray, 1987; Wein-the 1980s (Lewis & Murray, 1987 Weinberger, 1987) , but similar models were berger, 1987), but similar models were proposed by earlier researchers (Clouston, proposed by earlier researchers (Clouston, 1891; Southard, 1915; Pasamanick 1891; Southard, 1915; Pasamanick et al et al, , 1956 ). The success of this theory has been 1956). The success of this theory has been in its capacity to explain many of the in its capacity to explain many of the known features of schizophrenia. Thus, known features of schizophrenia. Thus, the season-of-birth effect, the reported the season-of-birth effect, the reported excess of obstetric complications, minor excess of obstetric complications, minor physical anomalies, dermatoglyphic ab-physical anomalies, dermatoglyphic abnormalities and childhood developmental normalities and childhood developmental impairments may all be successfully and impairments may all be successfully and usefully explained in relation to the influ-usefully explained in relation to the influence of environmental and epigenetic fac-ence of environmental and epigenetic factors on normal foetal brain development. tors on normal foetal brain development. Crucial supportive evidence for the theory Crucial supportive evidence for the theory was given by studies showing that classical was given by studies showing that classical degenerative brain changes were largely ab-degenerative brain changes were largely absent, by the presence of microscopic brain sent, by the presence of microscopic brain changes indicative of abnormal brain devel-changes indicative of abnormal brain development, and by the absence of clear evi-opment, and by the absence of clear evidence for progressive ventricular dilation dence for progressive ventricular dilation among people with schizophrenia. among people with schizophrenia.
However, these latter findings are no However, these latter findings are no longer secure. For example, the absence of longer secure. For example, the absence of excess cortical gliosis is no longer accepted excess cortical gliosis is no longer accepted as indicating a lack of perinatal or post-as indicating a lack of perinatal or postnatal cerebral inflammation, and firm cyto-natal cerebral inflammation, and firm cytoarchitectural evidence of abnormal brain architectural evidence of abnormal brain development has yet to be consistently development has yet to be consistently presented (Harrison, 1999) . Furthermore, presented (Harrison, 1999) . Furthermore, some neuroimaging studies have shown evi-some neuroimaging studies have shown evidence for progressive brain volume reduc-dence for progressive brain volume reductions over time (Mathalon tions over time (Mathalon et al et al, 2001) , 2001) and others have shown that hippocampal and others have shown that hippocampal volume reductions occur during the phase volume reductions occur during the phase of a first psychotic episode (Lawrie of a first psychotic episode (Lawrie et al et al, , 2000; Pantellis 2000; Pantellis et al et al, 2000) . Reversibility , 2000) . Reversibility of superior temporal gyrus volume reduc-of superior temporal gyrus volume reductions has also been described during the tions has also been described during the first episode of psychosis (Keshavan first episode of psychosis (Keshavan et al et al, , 1998) , and progressive cortical reductions 1998), and progressive cortical reductions are observed in people with early-onset are observed in people with early-onset schizophrenia (Thompson schizophrenia (Thompson et al et al, 2001) . , 2001). Thus, evidence is accumulating to support Thus, evidence is accumulating to support the view that plastic changes in macro-the view that plastic changes in macroscopic cytoarchitecture may occur with scopic cytoarchitecture may occur with illness. illness.
The microscopic basis of these cortical The microscopic basis of these cortical volume reductions is not known, but clues volume reductions is not known, but clues are provided by recent neuropathological are provided by recent neuropathological studies which show reductions in cortical studies which show reductions in cortical neuronal size, dendritic complexity and sy-neuronal size, dendritic complexity and synaptic proteins in schizophrenia (Harrison, naptic proteins in schizophrenia (Harrison, 1999) . Smaller neurons with fewer and 1999). Smaller neurons with fewer and less elaborate branches would result in a less elaborate branches would result in a diminution in the amount of neuropil, more diminution in the amount of neuropil, more compacted cells, and thus increased neuro-compacted cells, and thus increased neuronal density. It is certainly feasible to suggest nal density. It is certainly feasible to suggest that these alterations underlie the regional that these alterations underlie the regional cortical volume reductions observed in cortical volume reductions observed in schizophrenia. The current challenge, how-schizophrenia. The current challenge, however, is to understand the mechanism ever, is to understand the mechanism underlying these changes. The term underlying these changes. The term 'atrophic' is preferred to 'degenera 'atrophic' is preferred to 'degenerative' tive' because evidence of cell death and of the because evidence of cell death and of the gliotic response so characteristic of de-gliotic response so characteristic of degenerative diseases is absent. However, generative diseases is absent. However, regardless of terminology, the findings regardless of terminology, the findings necessitate a re-evaluation of the neuro-necessitate a re-evaluation of the neurodevelopmental hypothesis of schizophrenia developmental hypothesis of schizophrenia as described by Lewis & Murray (1987) . as described by Lewis & Murray (1987) . ) argue for disease-specific processes. However, simila-disease-specific processes. However, similarities in the neuropathology of schizo-rities in the neuropathology of schizophrenia, major depressive disorder and phrenia, major depressive disorder and bipolar disorder suggest that a common bipolar disorder suggest that a common process of change might be involved. These process of change might be involved. These findings are not discordant, for they argue findings are not discordant, for they argue that the observed pathology that the observed pathology in these dis-in these disorders might be the product orders might be the product of both of both disease-specific and non-specific processes. disease-specific and non-specific processes.
EVIDENCE FOR A COMMON EVIDENCE FOR A COMMON
What pathological changes are shared? What pathological changes are shared? First, macroscopic neuroanatomical investi-First, macroscopic neuroanatomical investigations of brain changes in schizophrenia, gations of brain changes in schizophrenia, bipolar disorder and major depressive dis-bipolar disorder and major depressive disorder show differences that are generally order show differences that are generally quantitative rather than qualitative. For quantitative rather than qualitative. For example, ventricular dilation and reduced example, ventricular dilation and reduced hippocampal and frontal brain volumes hippocampal and frontal brain volumes are seen in schizophrenia, but they are also are seen in schizophrenia, but they are also present to a lesser degree in major present to a lesser degree in major depressive disorder and bipolar disorder depressive disorder and bipolar disorder (McCarley (McCarley et al et al, 1999) . The single main , 1999). The single main departure from this pattern is that the departure from this pattern is that the volume of the amygdala may be specifically volume of the amygdala may be specifically enlarged in bipolar disorder (Altshuler enlarged in bipolar disorder (Altshuler et al et al, , 1998) , possibly because of drug treatment, 1998), possibly because of drug treatment, although this is not yet resolved. Second, although this is not yet resolved. Second, at the microscopic level, reductions in den-at the microscopic level, reductions in dendritic spine density (Rosoklija dritic spine density (Rosoklija et al et al, 2000) , , 2000), neuronal size (Rajkowska neuronal size (Rajkowska et al et al, 1999; , 1999; Cotter Cotter et al et al, 2001 , 2001a a, 2002 and synaptic , 2002) and synaptic proteins (Eastwood & Harrison, 2001) proteins (Eastwood & Harrison, 2001) have been described in both mood disorders have been described in both mood disorders and schizophrenia (Harrison, 1999) . Final-and schizophrenia (Harrison, 1999) . Finally, it has now become apparent that glial ly, it has now become apparent that glial cell deficit may also be a feature of major cell deficit may also be a feature of major depressive disorder, bipolar disorder and depressive disorder, bipolar disorder and schizophrenia (Rajkowska schizophrenia (Rajkowska et al et al, 1999; , 1999; Cotter Cotter et al et al, 2001 , 2001a a, , b b, 2002 , depending , 2002), depending possibly on the coexistence of affective possibly on the coexistence of affective symptoms and on which region of the brain symptoms and on which region of the brain is investigated. Although the latter finding's is investigated. Although the latter finding's functional and aetiological significance is functional and aetiological significance is not yet clear, it further not yet clear, it further demonstrates a demonstrates a similar brain pathology in similar brain pathology in these disorders these disorders and may provide an important clue to iden-and may provide an important clue to identifying aspects of the underlying disease tifying aspects of the underlying disease processes. processes.
The similarity of these patterns of The similarity of these patterns of changes in cortical cellular architecture in changes in cortical cellular architecture in schizophrenia and mood disorders suggests schizophrenia and mood disorders suggests that a common biological mechanism may that a common biological mechanism may underlie aspects of these psychiatric dis-underlie aspects of these psychiatric diseases. What aspects of illness common to eases. What aspects of illness common to major depressive disorder, bipolar disorder major depressive disorder, bipolar disorder and schizophrenia could cause changes in and schizophrenia could cause changes in keeping with the known cellular changes keeping with the known cellular changes described above? We do not propose that described above? We do not propose that this common process is necessarily primary this common process is necessarily primary to the pathophysiology of these disorders -to the pathophysiology of these disordersrather, that a single biological mechanism rather, that a single biological mechanism might participate in an important way in might participate in an important way in the development of the observed neuro-the development of the observed neuropathological (micro-and pathological (micro-and macroscopic) macroscopic) abnormalities. Glucocorticoid-abnormalities. Glucocorticoid-related neuro-related neurotoxicity is a candidate that needs to be toxicity is a candidate that needs to be considered. considered.
ROLE OF ROLE OF GLUCOCORTICOIDS GLUCOCORTICOIDS
There is substantial evidence that hyper-There is substantial evidence that hyperactivity of the hypothalamic-pituitary-activity of the hypothalamic-pituitaryadrenal (HPA) axis is involved in the adrenal (HPA) axis is involved in the pathogenesis of mood disorder (Pariante pathogenesis of mood disorder (Pariante & Miller, 2001) . Impaired function of the & Miller, 2001) . Impaired function of the glucocorticoid receptor and subsequent glucocorticoid receptor and subsequent altered feedback inhibition by endogenous altered feedback inhibition by endogenous glucocorticoids probably represents the glucocorticoids probably represents the mechanism by which the HPA axis is activ-mechanism by which the HPA axis is activated in depression. In contrast, until recently ated in depression. In contrast, until recently there was no firm evidence that HPA hyper-there was no firm evidence that HPA hyperactivity is part of the pathogenesis of schizo-activity is part of the pathogenesis of schizophrenia. The rate of non-suppression to the phrenia. The rate of non-suppression to the dexamethasone suppression test in dexamethasone suppression test in schizo-schizophrenia varies from 0% to 70%, with a mean phrenia varies from 0% to 70%, with a mean rate of approximately 20% (Sharma rate of approximately 20% (Sharma et al et al, , 1988) , which is much lower than that de-1988) , which is much lower than that described in depression (Evans scribed in depression (Evans et al et al, 1983) , 1983) but still higher than in the normal popu-but still higher than in the normal population (Sharma lation (Sharma et al et al, 1988) . The range , 1988) . The range appears to reflect the type of patient, the appears to reflect the type of patient, the activity of the patient, the presence of asso-activity of the patient, the presence of associated symptoms of depression and the ciated symptoms of depression and the effect of hospitalisation. Indeed, in schizo-effect of hospitalisation. Indeed, in schizophrenia there is evidence that patients phrenia there is evidence that patients who are clinically stable and receiving who are clinically stable and receiving treatment tend to have a normal HPA axis treatment tend to have a normal HPA axis (Tandon (Tandon et al et al, 1991; Ismail , 1991; Ismail et al et al, 1998 Ismail et al et al, ), , 1998 ), but patients who are drug-free or in the but patients who are drug-free or in the acute phase of the illness have an activated acute phase of the illness have an activated HPA axis (Holsboer-Trachsler HPA axis (Holsboer-Trachsler et al et al, 1987; , 1987; Tandon Tandon et al et al, 1991) . This suggests, cru-, 1991). This suggests, crucially, that the inconsistencies of the HPA cially, that the inconsistencies of the HPA axis changes observed in schizophrenia axis changes observed in schizophrenia may be because fewer studies have assessed may be because fewer studies have assessed patients during the acute phase of patients during the acute phase of the schi-the schizophrenic illness, which is the very period zophrenic illness, which is the very period most likely to be associated with a stress-most likely to be associated with a stressrelated elevation of glucocorticoids. More-related elevation of glucocorticoids. Moreover, reduced glucocorticoid receptor gene over, reduced glucocorticoid receptor gene expression has been described in the fron-expression has been described in the frontal cortex in schizophrenia and major tal cortex in schizophrenia and major depressive disorder (Webster depressive disorder (Webster et al et al, 2000) ,
, providing some evidence that HPA axis providing some evidence that HPA axis abnormalities may indeed be present in abnormalities may indeed be present in both these disorders, albeit mediated by both these disorders, albeit mediated by different mechanisms. different mechanisms.
Several other lines of investigation sup-Several other lines of investigation support the view that glucocorticoid-related port the view that glucocorticoid-related neurotoxicity may be implicated in depres-neurotoxicity may be implicated in depression and schizophrenia. First, investigations sion and schizophrenia. First, investigations in vitro in vitro have shown that high levels of have shown that high levels of glucocorticoid hormones result in reduced glucocorticoid hormones result in reduced neuronal volume and dendritic arborisation neuronal volume and dendritic arborisation (Sapolsky, 2000) , and these changes have (Sapolsky, 2000) , and these changes have been observed in both disorders. Second, been observed in both disorders. Second, elevated plasma glucocorticoid levels are elevated plasma glucocorticoid levels are associated with hippocampal volume re-associated with hippocampal volume reductions in major depressive disorder, ductions in major depressive disorder, post-traumatic stress disorder, Cushing's post-traumatic stress disorder, Cushing's disease and normal ageing, and such reduc-disease and normal ageing, and such reduc- Consequently the glial deficit found in these disorders may also relate to found in these disorders may also relate to glucocorticoid-related effects. glucocorticoid-related effects.
At present one can only speculate At present one can only speculate whether this putative link between gluco-whether this putative link between glucocorticoid hormones and macroscopic brain corticoid hormones and macroscopic brain changes in schizophrenia is exerted mainly changes in schizophrenia is exerted mainly through permanent damage of the brain through permanent damage of the brain cells or through reversible changes in the cells or through reversible changes in the neuropil structure. In animals, stress-neuropil structure. In animals, stressinduced changes in dendritic arborisation induced changes in dendritic arborisation are reversible after the stressor is elimi-are reversible after the stressor is eliminated, unless the stress is severe and pro-nated, unless the stress is severe and protracted over weeks or months (Sapolsky, tracted over weeks or months (Sapolsky, 1996) . Moreover, the hippocampal volume 1996). Moreover, the hippocampal volume reduction in people with Cushing's disease reduction in people with Cushing's disease is also reversible after normalisation of is also reversible after normalisation of cortisol levels (Sapolsky, 2000) . Evidence cortisol levels (Sapolsky, 2000) . Evidence in psychiatric disorders is less clear and in psychiatric disorders is less clear and the mechanisms may be different in differ-the mechanisms may be different in different phases of the disorders. For example, ent phases of the disorders. For example, the temporal gyrus volume reductions the temporal gyrus volume reductions described during the first episode of psy-described during the first episode of psychosis seem to be reversible (Keshavan chosis seem to be reversible (Keshavan et al et al, 1998) , but the hippocampal reduc-, 1998), but the hippocampal reductions described in patients with a long tions described in patients with a long history of major depressive disorder are history of major depressive disorder are present even in stable patients with normal present even in stable patients with normal cortisol levels, and are correlated with the cortisol levels, and are correlated with the length of illness (Sapolsky, 2000) . Re-length of illness (Sapolsky, 2000) . Reassuringly, a recent study has found mini-assuringly, a recent study has found minimal or no evidence of apoptosis in the mal or no evidence of apoptosis in the post-mortem analysis of the hippocampus post-mortem analysis of the hippocampus from patients with major depression from patients with major depression (Lucassen (Lucassen et al et al, 2001 ), suggesting that the , 2001), suggesting that the main alterations may involve potentially main alterations may involve potentially reversible changes to neuropil, glia and reversible changes to neuropil, glia and dendrites. dendrites.
Despite this evidence supporting the Despite this evidence supporting the view that interactions between glucocorti-view that interactions between glucocorticoid hormones and the brain might be coid hormones and the brain might be abnormal in major depressive disorder abnormal in major depressive disorder and schizophrenia, there remain some un-and schizophrenia, there remain some unanswered questions. First, it is not at all answered questions. First, it is not at all clear whether the mechanism of neurotoxi-clear whether the mechanism of neurotoxicity city in vivo in vivo is mediated through elevated or is mediated through elevated or lowered levels of cerebral glucocorticoids, lowered levels of cerebral glucocorticoids, for very low levels also have neurotoxic for very low levels also have neurotoxic effects (Sapolsky, 2000) . Second, reduced effects (Sapolsky, 2000) . Second, reduced glucocorticoid receptor function is ob-glucocorticoid receptor function is observed in individuals with major depression served in individuals with major depression (Pariante & Miller, 2001) or undergoing (Pariante & Miller, 2001) or undergoing severe psychological stress (Bauer severe psychological stress (Bauer et al et al, , 2000) , suggesting that elevated plasma cor-2000), suggesting that elevated plasma cortisol levels could represent a compensatory tisol levels could represent a compensatory strategy. Third, studies indicate that levels strategy. Third, studies indicate that levels of cortisol in the human brain are regulated of cortisol in the human brain are regulated by efflux systems at the blood-brain barrier by efflux systems at the blood-brain barrier (De Kloet (De Kloet et al et al, 1998) , and that both the , 1998), and that both the glucocorticoid receptor and the cortisol glucocorticoid receptor and the cortisol efflux systems may be influenced by psy-efflux systems may be influenced by psychotropic drugs (Pariante & Miller, 2001; chotropic drugs (Pariante & Miller, 2001; Pariante Pariante et al et al, 2001) . This indicates that , 2001). This indicates that peripheral cortisol levels may not neces-peripheral cortisol levels may not necessarily dictate cerebral levels, as is often sarily dictate cerebral levels, as is often assumed in studies. Finally, adjuvant anti-assumed in studies. Finally, adjuvant antidepressant effects have been demonstrated depressant effects have been demonstrated not only with compounds that stimulate not only with compounds that stimulate glucocorticoid receptor function (e.g. dexa-glucocorticoid receptor function (e.g. dexamethasone, prednisolone) but also with methasone, prednisolone) but also with compounds that inhibit its function compounds that inhibit its function (e.g. RU486, ketoconazole). Therefore, (e.g. RU486, ketoconazole). Therefore, whether patients with major depression whether patients with major depression or schizophrenia have elevated or or schizophrenia have elevated or lowered activation of the glucocorticoid lowered activation of the glucocorticoid receptor within the brain is yet to be fully receptor within the brain is yet to be fully elucidated. elucidated.
Further development of this hypothesis Further development of this hypothesis will require research into HPA function in will require research into HPA function in these disorders, such as post-mortem brain these disorders, such as post-mortem brain investigations into levels of corticotrophin-investigations into levels of corticotrophinreleasing hormone in the paraventricular releasing hormone in the paraventricular nucleus of the thalamus in schizophrenia nucleus of the thalamus in schizophrenia and bipolar disorder, and and bipolar disorder, and in vivo in vivo study of study of the relationship between glucocorticoid re-the relationship between glucocorticoid receptor function, cortisol levels and brain ceptor function, cortisol levels and brain changes in patients with depression and changes in patients with depression and schizophrenia at various stages of these schizophrenia at various stages of these illnesses. illnesses.
CONCLUSION CONCLUSION
Evidence is accumulating that brain Evidence is accumulating that brain changes occur during and possibly after changes occur during and possibly after the period of the first acute psychosis -the period of the first acute psychosischanges that are not purely developmental changes that are not purely developmental in the traditional sense. Furthermore, these in the traditional sense. Furthermore, these S T R E S S AND THE D E V E LOP M E N TA L HY P OTHE S I S OF S CHI ZOP HR E NI A S T R E S S AND THE D E V E LOP M E N TA L HY P OT HE S I S OF S CHI ZOP HR E NI A alterations are not specific to schizo-alterations are not specific to schizophrenia, in terms of either macroscopic phrenia, in terms of either macroscopic or microscopic brain structure, for they or microscopic brain structure, for they are also present to a generally milder degree are also present to a generally milder degree in people with mood disorder, and are in people with mood disorder, and are in keeping with glucocorticoid-related in keeping with glucocorticoid-related brain changes. Although it is possible -brain changes. Although it is possibleeven likely -that these brain changes even likely -that these brain changes are secondary to stress-related changes in are secondary to stress-related changes in glucocorticoid hormones rather than glucocorticoid hormones rather than primary pathogenetic pathways, they may primary pathogenetic pathways, they may none the less have crucial clinical effects none the less have crucial clinical effects through diminishing neuronal and cortical through diminishing neuronal and cortical function. This is because these brain function. This is because these brain changes may complicate recovery from the changes may complicate recovery from the primary illness. In the future, it may be primary illness. In the future, it may be possible to reverse these changes by therapies possible to reverse these changes by therapies that protect against glucocorticoid-related that protect against glucocorticoid-related neurotoxicity or promote neuroprotective neurotoxicity or promote neuroprotective cell signalling pathways. In the meantime, cell signalling pathways. In the meantime, however, the developmental theory of however, the developmental theory of schizophrenia as presented by Lewis & schizophrenia as presented by Lewis & Murray (1987) and Weinberger (1987) is Murray (1987) and Weinberger (1987) is challenged, for alone it is insufficient to challenged, for alone it is insufficient to explain the unfolding neuroanatomy of the explain the unfolding neuroanatomy of the disorder, which now seems likely to involve disorder, which now seems likely to involve both early developmental and later atrophic both early developmental and later atrophic processes. Targeting these later processes processes. Targeting these later processes may offer crucial therapeutic opportunities. may offer crucial therapeutic opportunities. 
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